Background: Unfavourable circulatory system conditions have been observed in many patients with spinal anaesthesia. The most frequent symptoms include a decrease in blood pressure and, less frequently, bradycardia. The appearance of unfavourable consequences of spinal anaesthesia might be related to the initial status of the patient's circulatory system. The aim of this study was to establish the possibility of predicting unfavourable circulatory consequences (hypotension, bradycardia) following spinal anaesthesia, based on non-invasive haemodynamic assessment with a Nexfin device. Methods: This prospective study included 100 18-60-year-old ASA I or II planned spinal anaesthesia patients. The initial hemodynamic parameters were assessed with a Nexfin monitor. Anaesthesia was performed with 3−3.5 mL of a 0,5% hyperbaric bupivacaine solution. Within 20 min after the administration of anaesthesia, the arterial blood pressure values, heart rate, sensory blockade level, and motoric blockade level were recorded in 5-min intervals. Hypotension was classified by a decrease of SAP < 90 mm Hg and/or the decrease of the SAP ≥ 20% initial value. Logistic regression was used to determine the independent predictors of hypotension resulting from a spinal blockade. Results: The development of hypotension and bradycardia was observed in 39 and 2%, respectively, of the patients. The patients who developed hypotension differed significantly from those who did not develop this symptom, with the main difference being the body mass and the assessment on the ASA scale. The patients who developed hypotension after spinal anaesthesia differed significantly in the initial hemodynamic parameters (SAP, MAP, SVRI). The following two independent risk factors for hypotension were isolated: the mean arterial pressure (OR 1.04; 95% CI: 1.005-1.076) and the systemic vascular resistance index (OR 1.109; 95% CI: 1.021-1.204). Conclusions: Nexfin-based non-invasive haemodynamic monitoring might be helpful in the identification of individuals with a high risk of hypotension following spinal blockade.
Spinal anaesthesia (SA) is a safe method for ensuring painlessness during various surgical procedures. The most common adverse effects of SA are hypotension and bradycardia. The incidences of hypotension and significant bradycardia with anaesthetic procedures are 15−38% and approximately 10%, respectively [1−3] . Severe complications resulting in cardiac arrest are extremely rare.
The occurrence and extent of haemodynamic disorders following SA are unpredictable. The risk factors for their development have not been explicitly identified, and they could be associated with the baseline circulatory status. The data regarding this issue are scarce because of the invasiveness of the methods used to assess comprehensively the functions of the cardiovascular system. Modern medical technology offers tools that enable non-invasive estimation of some haemodynamic parameters, including the Nexfin device (Bmeye, Amsterdam, Netherland), which is based on reconstruction of the brachial artery and aortic pressure waves, supplemented with unique dynamic and hydrostatic calibration algorithms (Physical and HRS). The device could be used to measure the following parameters: the systolic arterial pressure (SAP), diastolic arterial pressure (DAP), mean arterial pressure (MAP), and HR; it calculates cardiac output (CO) (the numerical form and trends), cardiac index (CI), and stroke volume (SV) [4] .
The aim of the study was to determine whether the risk factors for adverse circulatory effects of spinal anaesthesia, i.e., hypotension and bradycardia, could be identified using simple, non-invasive haemodynamic tests and anthropometric data.
METHODS
The study design was approved by the Independent Bioethics Committee of the Medical University of Gdańsk. The prospective study encompassed 100 patients of both sexes undergoing elective surgical procedures. All the patients gave their written informed consent. The inclusion criteria were age of 18-60 years, ASA I or II, and qualification for surgery routinely performed under spinal anaesthesia (SA). The exclusion criteria were lack of patient's consent for participation, lack of consent for SA, and a history of allergy to local anaesthetics as well as concomitant diseases such as arterial hypertension, diabetes mellitus, ischaemic heart disease, and disorders of heart rhythm and conduction.
The patients included in the study fasted from 8 pm on the day preceding surgery. with liquids being allowed until midnight. On the day of surgery, the patient was premedicated with 7.5 mg of oral midazolam 30 minutes before transfer to the operating suite. In the operating room, the patient was placed in the dorsal decubitus position and a cannula was inserted into the right upper limb vein to supply the electrolyte solution in a volume lower than 200 mL. The arterial pressure was measured classically (by oscillometry), the cuff placed on the right arm. The arterial blood haemoglobin saturation was determined using transdermal pulsoxymetry, and the lead II ECG recordings were continuously monitored. The finger cuff of the Nexfin device, adjusted to the finger size, was placed on the index or third finger, and two static pressure sensors were connected, one onto a free finger of the left hand and the other placed at the heart level. The wires of the cuff and sensors met in the measurement module placed over the left wrist. The following baseline (before SA) values were recorded: SV, stroke volume index (SVI), cardiac output (CO), CI and SVR. The systemic vascular resistance index (SVRI) was calculated using the formula: SVRI = 80 (MAP -RAP) × CI -1 , where RAP is the right atrial pressure. A RAP value of 4 mm Hg was accepted arbitrarily because the non-invasive methods used did not allow determination of its real value. This value was assumed to be a mean of the RAP values in patients without cardiovascular conditions (based on [5] ).
For anaesthesia, 3.0 to 3.5 mL of a 0.5% hyperbaric solution of bupivacaine was administered, with the patient in the reclining position at the L3-L4 or L4-L5 level, using a 26 needle (Atraucan, B-Braun Melsungen AG, Melsungen, Germany). After the anaesthesia, the patient was placed in the recumbent position, and the arterial pressure and heart rate were measured for the next 20 minutes at five-minute intervals, using the classic non-invasive method. The degree of sensory block (the cold sensation test) and of motor block (the Bromage scale) were assessed at the same measurement points (Table 1) .
SAP values < 90 mg Hg and /or a decrease in SAP ≥ 20% of the baseline value were considered hypotension, which determined the division of patients into the following groups: the HO group included patients with significant decreases in arterial pressure, and the H1 group included patients who developed significant hypotension. A decrease in HR below 50 min -1 was considered bradycardia.
In cases in which the decreases in arterial pressure required treatment, 5 mg of IV ephedrine was administered and repeated to the effective dose, which in total did not exceed 25 mg. The ephedrine supply was dependent on the patient's general condition and the reported complaints. In cases of bradycardia below 50 min -1 , IV atropine was administered in a dose 0.5−1.0 mg.
The statistical analysis was performed using Statistica 10.0 PL software (StatSoft, Tulsa, USA). The group size was determined to be 100 individuals. A maximum of 10 parameters was used in the multivariate logistic regression analysis, which would reach the P < 0.20 level of significance in the univariate analysis.
The data on the interval scale were verified for normality of distribution using the Shapiro-Wilk W test; in the compar- ative analyses, the Levene test of homogeneity of variance was used. In the comparisons of the two data groups, the Student's t-test for independent samples or its modification, with a separate analysis of variance, was applied. In the multiple comparisons, ANOVA for repeated measurements was used. In justified cases, the Tukey`s post-hoc honestly significant difference (HSD) test was applied.
The data on the nominal scale were compared using the χ 2 or Fischer-Snedecor test. The risk factors of adverse effects were determined using logistic regression with quasiNewton estimation. The multivariate stepwise regression analysis included the parameters with P < 0.20 in the multivariate analysis. In all the analyses, P < 0.05 was considered significant.
RESULTS
The demographic parameters and the data regarding anaesthesia for the entire study population are presented in Table 2 . The characteristics of subarachnoid block are listed in Table 3 .
Significant decreases in arterial pressure following spinal anaesthesia were observed in 39 group H1 patients (39%). The remaining 61 patients (61%) did not develop hypotension and were included in group HO. Bradycardia was found in 2 patients (2% of the study population).
Considering the sporadic cases of bradycardia, a comparative analysis of the groups and analysis of the risk factors of adverse consequences of SA were performed exclusively on the occurrence of hypotension. Table 4 presents the comparison of the demographic data and the baseline haemodynamic parameters (before SA) for the HO and H1 groups. There were no intergroup differences in the number of anaesthetized segments and the extent of motor block at any measurement point. The results of the univariate analysis of the risk factors of hypotension performed using the logistic regression method are presented in Table 5 . A multivariate analysis allowed the identification of the following independent risk factors of hypotension associated with spinal anaesthesia: MAP before anaesthesia (OR 1.040; 95% CI for OR: 1.005-1.076; P = 0.023) and baseline SVRI (OR 1.109; 95% CI for OR: 1.021−1.204; P =0.013).
The P values for these parameters (the Wald test) were 0.021 and 0.013, respectively.
Four patients (1 from group H0 and 3 from group H1) developed bradycardia and were administered atropine. Although bradycardia, defined as HR < 50 min -1 , developed in 2 patients, the attending anaesthetist administered an anticholinergic drug to the remaining 2 patients because the HR rapidly slowed. In each case, 0.5 mg of IV atropine was administered. Ephedrine was administered to 12 patients in the H1 group (30.8%) and to 0 patients in the H0 group. In the majority of cases, 5 mg of the drug was given intravenously one time (7 patients); less commonly, 10 mg was initially administered (5 patients). The dose of ephedrine was repeated in 3 individuals, and 2 patients who received 10 mg were administered an additional dose of 5 mg.
DISCUSSION
Hypotension associated with subarachnoid block anaesthesia is common. Bradycardia is observed less frequently. Hypotension and bradycardia occurred in 39% and 2%, respectively, of our patients. Our findings regarding the incidence of decreased arterial pressure are comparable with those reported by other authors; the incidence of decreased HR found in our material differs from that presented in the literature. In a large population study of patients, the incidence of bradycardia has been estimated at approximately 9% for moderate bradycardia of 40-50 min -1 and at 0.7% for severe bradycardia, with an HR below 40 min -1 [6] . Because of noticeable inconsistencies in the cut-off value of HR, comparing results is difficult. In some studies, the accepted cut-off value of HR is < 60 min -1 [7] , i.e., 20% higher than the value assumed in our study. In adults, a HR of 60 min -1 should be considered a cut-off value for bradycardia after spinal anaesthesia only in pregnant women, which is a finding confirmed in literature reports [8, 9] . The risk factors of moderate bradycardia include a baseline HR < 60 min -1 , male gender, age below 37 years, elective surgery, ASA I, and preoperative use of beta-adrenergic blocking agents [6] . In our population, the risk factors were predominantly the elective nature of surgery, ASA (I in 86% of individuals), and gender distribution; 46% of our patients were less than 37 years old, 8% had a baseline HR below 60 min -1 and none of our patients underwent beta-adrenolytic therapy. Anaesthetic procedures involving the majority of thoracic segments from the 15 th minute of the study predominated in our population. Considering that the sympathetic block level is 1−4 segments higher than that of the sensory block [10, 11] , at least some patients should have had a conduction block in the fibres forming the cardiac plexus (Th1-Th4) and should have developed bradycardia. The literature data [1, 11] have revealed substantial individual differences in haemodynamic responses to the level of block, which was confirmed by our findings. A significant drop in arterial pressure occurred in 39% of our patients. According to literature data, the incidence of hypotension ranges from 30% to 90% [12, 14] . Such a high incidence ensures that, in the majority of cases, it is difficult to consider hypotension as a complication of central block. Apart from rare cases of very large decreases in arterial pressure, hypotension is rather an adverse effect. There are obviously patients whose arterial pressure decreases are highly undesirable and the methods to counteract them are therefore employed, i.e., the elderly, in whom arterial pressure drops can lead to reduced blood flow through the cerebral and coronary vessels and its sequels [15, 17] . The difficulties in comparing the incidences of hypotension result from different definitions assumed by various authors. In our study, hypotension was considered a reduction in SAP < 90 mm Hg and/or a decrease in SAP ≥ 20% of the baseline value. The definition accepted by us is quite commonly used in research with various groups of patients [18, 19] . Hypotension is frequently prevented by using pre-emptive intravenous or intramuscular ephedrine or preloading (of crystalloids or colloids) before a spinal block. The use of each of these methods in individuals with cardiovascular diseases could lead to the following unfavourable consequences: tachycardia and arrhythmias (in the former method) or circulatory overload (in the latter case) [10, 20] .
The preventive methods used are not harmLess to anaesthetized patients. Research on new risk factors for hypotension and bradycardia is on going, using low-invasive methods of haemodynamic monitoring [21] . Easily measurable risk factors for adverse circulatory consequences of spinal anaesthesia are individual patient characteristics, e.g., age, gender, body mass or its index (BMI).
In the study population, there were no intergroup differences in age, body mass, height or BSA, whereas the difference in the BMI was significant, with the H1 patients having a higher BMI than the H0 patients. A significant factor for the development of hypotension is the age of the anaesthetized patients. Higher incidences of hypotension are observed in the elderly, i.e., 70−75% [20, 22] . In our population, the patients were under 60 years of age, and the age-related risk was irrelevant. The height of the anaesthetized patients in the studies was not a significant predictor of hypotension regarding the general population, which is consistent with our findings [7, 12] . The incidence of hypotension following spinal anaesthesia is substantially affected by the level of subarachnoid space injection and the volume (dose) of a local anaesthetic. In our study, the space at the L3-L4 or L4-L5 level was assumed to be the injection sight, which explains the lack of intergroup differences concerning the level of the lumbar injection. The narrow range of doses of 0.5% hyperbaric bupivacaine administered at the subarachnoid space (15-17.5 mg) was the most likely reason for the lack of intergroup differences in this respect. Based on observations that haemodynamic disorders occur in some patients undergoing spinal anaesthesia, it could be assumed that the baseline cardiovascular status affects their development. There are virtually no data on the use of more advanced techniques of haemodynamic monitoring for prediction of hypotension after spinal anaesthesia, which predominantly results from the invasiveness of such techniques. The most easily measureable haemodynamic parameter that could be used to determine the risk of hypotension following spinal anaesthesia is arterial pressure. In spinal anaesthesia cases, increased risks were noted for SAP below 120 mm Hg [12] . In our population, the univariate analysis of variance demonstrated that the incidence of hypotension was associated with higher values of SAP as well as MAP and was not affected by DAP values. In multivariate analysis, only MAP was found to be an independent risk factor of hypotension. Our observations differ from those reported by Carpenter et al. [12] , yet are comparable with observations of a study from California (for SAP) [23] , which studied pregnant women. To interpret the results, measurements of other haemodynamic parameters should be considered and performed using the non-invasive Nexfin method; there were significant differences in the cardiac parameters (CO, CI, SV, SVI), yet a difference in SVRI was observed. This difference was parallel to that observed for MAP; i.e., the higher the SVRI value, the higher the risk of decreased arterial pressure. In addition to the MAP, the SVR was found to be the second independent risk factor of hypotension in the study population. If MAP is considered a reflection of vascular resistance and CO when there are no differences in cardiac output, it is not surprising that MAP and SVRI affected the incidence of arterial pressure drops in the study population. Similar observations were presented by Ouzounian et al. [23] in the above-mentioned study regarding pregnant women, which provided the only possibility to directly compare our results, as there are virtually no reports on this issue. Some findings demonstrate a distinct correlation between sympathetic tone and hypotension after spinal anaesthesia. In a study [24] involving an obstetric population, the anaesthetized patients of higher sympathetic activity before spinal block (expressed by a frequency analysis of the variability of cardiac rhythm) were more susceptible to hypotension. The authors did not study haemodynamic parameters; however, higher sympathetic tone is associated with higher SVRI and MAP values.
STUDY LIMITATIONS
The assumption of the study was non-invasive cardiovascular monitoring using the Nexfin monitor; however, we realized that the lower level of invasiveness of the measurement method could result in limited reliability of the results. The opinions regarding the device are positive regarding the reliability of arterial pressure measurements [25−27] ; however, the agreement of the Nexfin-based CO and SVR measurements is assessed cautiously, although the majority of authors rate it as quite good or good [21, 28, 29] . Another limitation is the arbitrarily assumed central venous pressure value and the basing of SVRI calculations on it.
Additional problems are the small numbers of studies regarding the usefulness of non-invasive methods for prediction of adverse consequences of SA and that the majority of literature studies concern pregnant women anaesthetized for a Caesarean section. Simple interpolation of such data into the non-obstetric population is not possible because of physiological changes that develop in pregnancy (including cardiac changes).
